597 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. D'Angelica
    D'Angelica
  4. Jarnagin
    Jarnagin
  5. Kemeny
    Kemeny
  6. Lichtman
    Lichtman
  7. Fong
    Fong
  8. Gonen
    Gonen
  9. Ilson
    Ilson
  10. Kingham
    Kingham

Groups

  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (372)
  3. Gastrointestinal Oncology Service (293)
  4. Center for Pancreatic Cancer Research (179)
  5. Surgery (167)
  6. Epidemiology and Biostatistics (76)
  7. Survivorship Research (76)
  8. Biostatistics Service (68)
  9. Population Sciences Research Program (63)
  10. Colorectal Surgery (59)
  1. "oxaliplatin"
Formats
  1. Journal Article (538)
  2. Review (36)
  3. Editorial (11)
  4. Correspondence (3)
  5. Conference Paper (2)
  6. Meeting Abstract (2)
  7. Miscellaneous (2)
  8. Book Section (1)
  9. Guidelines (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (407)
  2. Solid Tumor Oncology Division (372)
  3. Gastrointestinal Oncology Service (293)
  4. Center for Pancreatic Cancer Research (179)
  5. Surgery (167)
  6. Epidemiology and Biostatistics (76)

More Groups

People
  1. Leonard Saltz (84)
  2. Nancy Kemeny (74)
  3. Eileen O'Reilly (64)
  4. Michael D'Angelica (51)
  5. William Jarnagin (49)
  6. Stuart Lichtman (45)

More People

Years
  1. 2025 (20)
  2. 2024 (55)
  3. 2023 (33)
  4. 2022 (27)
  5. 2021 (13)
  6. 2020 (17)

More Years

Publications
  1. Journal of Clinical Oncology (42)
  2. Annals of Surgical Oncology (38)
  3. Journal of the National Comprehensive Cancer Network (29)
  4. The Oncology Report (26)
  5. Annals of Oncology (16)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (99)
  2. Springer (75)
  3. American Society of Clinical Oncology (46)
  4. Oxford University Press (40)
  5. Wiley Blackwell (33)
  6. Elsevier Science, Inc. (29)

More Publishers

Results (597)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes
    Journal Article

    O'Reilly, E. M.; Cockrum, P.; Surinach, A.; Wu, Z.; Dillon, A.; Yu, K. H.
    Cancer Medicine (2020)

    Fulltext@MSK | Save
  • Pump-based hepatic arterial infusional therapy
    Book Section

    Mondaca, S.; Kemeny, N. E.
    In Fong, Y.; Gamblin, T. C.; Han, E. S.; Lee, B.; Zager, J. S. (Eds.) Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond (2020)

    Fulltext@MSK | Save
  • Locoregional therapy plus systemic chemotherapy in unresectable intrahepatic cholangiocarcinoma - In reply
    Correspondence

    Cercek, A.; Jarnagin, W. R.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: An open-label, single-arm, phase 2 trial
    Journal Article

    Janjigian, Y. Y.; Maron, S. B.; Chatila, W. K.; Millang, B.; Chavan, S. S.; Alterman, C.; Chou, J. F.; Segal, M. F.; Simmons, M. Z.; Momtaz, P.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases
    Guidelines

    Chicago Consensus Working Group
    Cancer (2020)

    Fulltext@MSK | Save
  • New treatment strategies for metastatic pancreatic ductal adenocarcinoma
    Review

    Singh, R. R.; O’Reilly, E. M.
    Drugs (2020)

    Fulltext@MSK | Save
  • Diabetes and clinical outcome in patients with metastatic colorectal cancer: CALGB 80405 (Alliance)
    Journal Article

    Brown, J. C.; Zhang, S.; Ou, F. S.; Venook, A. P.; Niedzwiecki, D.; Lenz, H. J.; Innocenti, F.; O'Neil, B. H.; Shaw, J. E.; Polite, B. N.; more...
    JNCI Cancer Spectrum (2020)

    Fulltext@MSK | Save
  • Immune checkpoint inhibition in colorectal cancer: Microsatellite instability and beyond
    Review

    Cohen, R.; Rousseau, B.; Vidal, J.; Colle, R.; Diaz, L. A. Jr; André, T.
    Targeted Oncology (2020)

    Fulltext@MSK | Save
  • The role of PARP inhibitors in germline BRCA-associated pancreatic ductal adenocarcinoma
    Review

    Moffat, G. T.; O’Reilly, E. M.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation
    Review

    Athauda, A.; Fong, C.; Lau, D. K.; Javle, M.; Abou-Alfa, G. K.; Morizane, C.; Steward, K.; Chau, I.
    Cancer Treatment Reviews (2020)

    Fulltext@MSK | Save